Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Appian Corp (APPN) vs Becton Dickinson and Co (BDX) Price & Performance

Appian CorpTrade
Becton Dickinson and CoTrade

Price performance (Past 24H)

Key statistics

Appian Corp vs Becton Dickinson and Co — how do they compare? Appian Corp trades at $35.5 (market cap $2.54B), while Becton Dickinson and Co trades at $180.75 (market cap $49.41B). The key difference: Becton Dickinson and Co is far larger — about 19.5× Appian Corp's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Appian Corp pays none. Which is the better fit depends on your goals.

APPNBDX
Market Cap
$2.54B$49.41B
Sector
TechnologyHealth
52-Week High
$45.64$185.39
52-Week Low
$18.72$138.62
Enterprise Value
$2.67B$65.51B
Dividend Yield
2.32%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Appian Corp

Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.

Read more on APPN

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX